In an era of superbugs, bioterrorism, and pandemics, the need for new technologies to fight a host of rapidly evolving and potentially deadly diseases has never been greater. In response to this need, Northern Arizona University is increasing its investment in the highly specialized fields of pathogen genomics, infectious disease ecology, and microbiome research.
Building on the recognized expertise of its faculty and their world-renowned contributions in the areas of anthrax and infectious diseases, the university launched the Pathogen and Microbiome Institute (PMI) in 2016. Representing a key investment in the technologies of the future, the new institute will greatly expand NAU’s capabilities to conduct both basic and translational research in the following areas:
• Pathogen microbiology
• The role of the microbiome in chronic healthcare challenges
• Hospital-acquired infections
• Biological Select Agents or Toxins (BSAT)